FARO is an Argentina company over 10 years of experience in the development and operation of integrated projects in the agribusiness sector. All projects FARO own position it as a reference and leader both locally and internationally. Among his various projects, FARO operates the largest tree planting pecan nut Latin America, with projection to become the largest southern hemisphere and one of the largest in the world. This project is structured under different vehicles, including Alto Pecan stands, the first real estate development of nautical fields planted with pecan nut Latin America, located in Villa Paranacito, Entre Ríos . Another project is AgroConsortium, productive trust for the production and marketing of cereals and oilseeds in leased farms located in different productive areas in Argentina and potentially in the region. Finally, thanks to the expertise acquired in agribusiness, FARO developed his own business model for productive land conversion. Its aim is to position rural properties whose productive potential is not reflected in the price and complement the cycle with the economic use of land in intensive production, short and medium term. Since 2006, the Investor Group is a strategic partner OMBU FARO for all investment portfolios development ventures related to agribusiness, that focus on supply both local and international markets.
Bionamic provides solutions for the analysis of life science data to reduce or eliminate the manual steps between raw data and results.
IntuiCell
Venture Round in 2021
IntuiCell develops a fundamentally new recursive computing architecture and associated technology platform.
SAGA Diagnostics
Series A in 2019
SAGA Diagnostics AB is a company specializing in molecular genetic tests and services aimed at enhancing cancer diagnostics and disease monitoring for healthcare providers, biopharmaceutical firms, and academic institutions. Founded in 2016 as a spin-out from a research group at Lund University, SAGA focuses on the analysis of circulating tumor DNA (ctDNA), a critical biomarker for cancer. The company offers a range of services, including gene mutation analysis, chromosome analysis, and non-invasive liquid biopsy testing, which allows for the ultrasensitive detection of actionable mutations. SAGA's proprietary technology supports oncologists and drug developers by enabling the stratification of patient groups and monitoring treatment responses, thereby facilitating more precise cancer medicine and improving patient outcomes. Based in Lund, Sweden, SAGA is driven by a team of experienced scientists and professionals dedicated to advancing cancer research and clinical diagnostics.
Aligned Bio
Aligned Bio specializes in the development of advanced nanowire biosensor platforms that cater to various industries, including biomedicine, water purification, public safety, and personal electronics. The company’s proprietary methods for nanowire production and alignment enhance the sensitivity and accuracy of its sensors, making them highly effective for applications such as disease diagnosis, pathogen identification, pesticide detection, and pollution monitoring. By leveraging the large area of nanowires and improved signal capacity, Aligned Bio enables sensor manufacturers to achieve superior performance at a reduced cost, positioning itself as a key player in the evolving biosensor and electronics markets.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.